Evidence map›Paper›PMID 36671896›Full record

ArticleBiosensors2022

Polarized Micro-Raman Spectroscopy and 2D Convolutional Neural Network Applied to Structural Analysis and Discrimination of Breast Cancer.

Linwei Shang, Jinlan Tang, Jinjin Wu, Hui Shang, Xing Huang, Yilin Bao, Zhibing Xu, Huijie Wang, Jianhua Yin

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Multi-Wavelength Raman Differentiation of Malignant Skin Neoplasms.International journal of molecular sciences · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Linwei ShangDepartment of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, China.
Jinlan TangDepartment of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, China.
Jinjin WuDepartment of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, China.
Hui ShangDepartment of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, China.
Xing HuangDepartment of Pathology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210016, China.
Yilin BaoDepartment of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, China.
Zhibing XuDepartment of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, China.
Huijie WangDepartment of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, China.ORCID 0000-0001-8954-9857
Jianhua YinDepartment of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, China.ORCID 0000-0002-2488-5283
Nanjing University of Aeronautics and Astronautics · CNJiangsu Cancer Hospital · CN

Funding

National Natural Science Foundation of China 62105147Prospective layout Special Fund of Nanjing University of Aeronautics and Astronautics ILA-22022the Fundamental Research Funds for the Central Universities NS2022035
6 · The paper itself

Abstract

Raman spectroscopy has been efficiently used to recognize breast cancer tissue by detecting the characteristic changes in tissue composition in cancerization. In addition to chemical composition, the change in bio-structure may be easily obtained via polarized micro-Raman spectroscopy, aiding in identifying the cancerization process and diagnosis. In this study, a polarized Raman spectral technique is employed to obtain rich structural features and, combined with deep learning technology, to achieve discrimination of breast cancer tissue. The results reconfirm that the orientation of collagen fibers changes from parallel to vertical during breast cancerization, and there are significant structural differences between cancerous and normal tissues, which is consistent with previous reports. Optical anisotropy of collagen fibers weakens in cancer tissue, which is closely related with the tumor's progression. To distinguish breast cancer tissue, a discrimination model is established based on a two-dimensional convolutional neural network (2D-CNN), where the input is a matrix containing the Raman spectra acquired at a set of linear polarization angles varying from 0° to 360°. As a result, an average discrimination accuracy of 96.01% for test samples is achieved, better than that of the KNN classifier and 1D-CNN that are based on non-polarized Raman spectra. This study implies that polarized Raman spectroscopy combined with 2D-CNN can effectively detect changes in the structure and components of tissues, innovatively improving the identification and automatic diagnosis of breast cancer with label-free probing and analysis.

Indexed as

Breast NeoplasmsBreastCollagenFemaleHumansNeural Networks, ComputerSpectrum Analysis, RamanCollagen2D-convolutional neural networkbreast cancerdiscriminationpolarized micro-Raman spectroscopy

Identifiers

PMID36671896
PMCPMC9856190
OpenAlexW4313472937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.